NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 58 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 810,073 | $9,980,000 | 6.05% |
| EcoR1 Capital, LLC | 3,915,880 | $48,244,000 | 4.35% |
| Opaleye Management Inc. | 1,381,300 | $17,018,000 | 3.34% |
| Avidity Partners Management LP | 210,000 | $2,587,000 | 1.63% |
| ACUTA CAPITAL PARTNERS, LLC | 372,500 | $4,589,000 | 1.14% |
| Boxer Capital, LLC | 1,009,255 | $12,434,000 | 0.70% |
| Redmile Group, LLC | 1,920,831 | $23,665,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 379,998 | $4,682,000 | 0.39% |
| Sio Capital Management, LLC | 88,185 | $1,086,000 | 0.26% |
| Baker Brothers Advisors | 3,397,740 | $41,860,000 | 0.22% |